Skip to main content
Swing Capital

Sai Life Sciences Ltd

NSE: SAILIFE BSE: 544306Pharma

Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries[1]

₹1,128
52W: ₹700 — ₹1139
PE 68.8 · Book ₹118 · +856% vs book
Market Cap₹23,889 Cr
Stock P/E68.8Price to Earnings
ROCE19.2%Return on Capital
ROE14.9%Return on Equity
Div. Yield0%Face Value ₹1

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 39.7% CAGR over last 5 years

Weaknesses

  • −Stock is trading at 9.16 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of 12.6% over last 3 years.

Shareholding Pattern

Promoters34.61%
FIIs21.17%
DIIs31.54%
Public12.69%
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters35.23%35.16%▼0.135.15%▼0.034.95%▼0.234.7%▼0.334.61%▼0.1
FIIs11.72%12.36%▲0.614.57%▲2.222.5%▲7.921.41%▼1.121.17%▼0.2
DIIs11.95%13.26%▲1.321.64%▲8.429.92%▲8.331.41%▲1.531.54%▲0.1
Public41.08%39.21%▼1.928.64%▼10.612.65%▼16.012.49%▼0.212.69%▲0.2

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales373428264382429567483527549594
Expenses279301240281317413370387370426
Operating Profit9412725101111154113140179168
OPM %25%30%9%26%26%27%23%27%33%28%
Net Profit4062-11445190588398103
EPS ₹00002.454.322.83.954.624.84

AI Insights

Revenue Trend

Mar 2026 revenue at ₹2,153Cr, up 31.1% YoY. OPM at 28%.

Debt Position

Borrowings at ₹223Cr. Debt-to-equity ratio: 0.09x. Healthy balance sheet.

Capex Cycle

CWIP at ₹270Cr (16% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 31.54% (+19.59pp change). FIIs: 21.17% (+9.45pp change). Promoters hold 34.61%.

Margin & Efficiency

ROCE improving from 0% (Mar 2019) to 19% (Mar 2026). Working capital days: 76.

Valuation

PE 68.8x with 19.2% ROCE. Price is 856% above book value of ₹118. Dividend yield: 0%.

Recent Announcements